Pulmonary Thromboembolism after Post-menopause Hormonal Replacement Therapy

Hormonal replacement therapy (HRT) has been proven for treatment of postmenopausal symptoms such as hot flushes, night sweats and urologic symptoms. HRT became very popular in the 1990's, when there were several reports showing that it also helped with other menopausal complications such as osteoporosis and cardiovascular disease. Recent studies report that the incidence of breast cancer, endometrial cancer, cerebral infarction, coronary artery diseases, deep vein thrombosis and pulmonary thrombembolism could rise after HRT. Among these side effects of HRT, the risk of pulmonary thromboembolism increases 2 to 4 fold after HRT, but can vary with the use of different doses and preparations. Here, we summarize the risk factors and clinical courses for 5 patients who developed pulmonary thromboembolism after postmenopausal HRT. (Tuberc Respir Dis 2007; 63: 362-366)

keywords: Postmenopause hormone replacement therapy(HRT), Pulmonary thromboembolism, Deep vein thrombosis., Postmenopause hormone replacement therapy(HRT), Pulmonary thromboembolism, Deep vein thrombosis.

Reference

(1996) Risk of venous thromboembolism in users of hormone replacement therapy,

(2005) Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? ,

(2002) Postmenopausal hormone replacement therapy,

(2006) A case of venous thrombosis developed in a woman taking oral contraceptives with antithrombin III, protein C and protein S deficiencies,

(2003) Differential association of oral and transdermal oestrogen- replacement therapy with venous thromboembolism risk,

(1997) Hormone replacement therapy and the risk of deep vein thrombosis,

(2005) Postmenopausal hormone replacement therapy and venous thromboembolism,

(1998) Oral contraceptives and venous thromboembolism,

(brmedj1986;292) findings in a large prospective study,

10.

(intjepidemiol1990;19) Oral contraceptive estrogen and progestin potencies and the incidence of deep venous thromboembolism,

11.

(amjepidemiol1991;133) Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease,

12.

(1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens,

바로가기메뉴

Article Contents

Vol.63 No.4

Pulmonary Thromboembolism after Post-menopause Hormonal Replacement Therapy

Abstract

Reference

Tuberculosis & Respiratory Diseases